These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35057017)

  • 21. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
    Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.
    Beikzadeh B; Nikbakht Brujeni G
    BMC Res Notes; 2018 May; 11(1):302. PubMed ID: 29769118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.
    Duan Q; Huang J; Xiao N; Seo H; Zhang W
    Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29079628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.
    Lu T; Moxley RA; Zhang W
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
    Svennerholm AM
    Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge.
    Coria LM; Martinez FL; Bruno LA; Pasquevich KA; Cassataro J
    Vaccine; 2020 Jul; 38(32):5027-5035. PubMed ID: 32536545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic
    Hui Xian T; Parasuraman S; Ravichandran M; Prabhakaran G
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine immunization with CS21 pili or LngA major subunit of enterotoxigenic Escherichia coli (ETEC) elicits systemic and mucosal immune responses and inhibits ETEC gut colonization.
    Zhang C; Iqbal J; Gómez-Duarte OG
    Vet Microbiol; 2017 Apr; 202():90-100. PubMed ID: 26878971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
    Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
    J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.
    O'Dowd A; Maciel M; Poole ST; Jobling MG; Rollenhagen JE; Woods CM; Sincock SA; McVeigh AL; Gregory MJ; Maves RC; Prouty MG; Holmes RK; Savarino SJ
    Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coimmunization with Two Enterotoxigenic Escherichia coli (ETEC) Fimbrial Multiepitope Fusion Antigens Induces the Production of Neutralizing Antibodies against Five ETEC Fimbriae (F4, F5, F6, F18, and F41).
    Duan Q; Wu W; Pang S; Pan Z; Zhang W; Zhu G
    Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32169934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli.
    Nazarian S; Gargari SL; Rasooli I; Hasannia S; Pirooznia N
    Microbiol Res; 2014; 169(2-3):205-12. PubMed ID: 23906742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic
    Hays MP; Kumar A; Martinez-Becerra FJ; Hardwidge PR
    Front Cell Infect Microbiol; 2016; 6():181. PubMed ID: 28018863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.